Bellevue Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,600
Closed -$1.24M 178
2022
Q3
$1.24M Buy
+6,600
New +$1.39M 0.02% 132
2020
Q2
Sell
-13,600
Closed -$1.31M 223
2020
Q1
$1.31M Hold
13,600
0.03% 137
2019
Q4
$1.26M Buy
+13,600
New +$1.14M 0.02% 147

Other funds holding RGEN

Bellevue Group's RGEN Position: Q4 2022 in Review

Bellevue Group sold out of Repligen (RGEN) in Q4 2022, closing a stake of 6,600 shares — an estimated $1.24M sold.

Bellevue Group first reported a position in RGEN in Q4 2019 and held it in 3 quarters. The position peaked at $1.31M in Q1 2020. 441 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

  • Bellevue Group reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
  • Bellevue Group sold 6,600 Repligen shares in Q4 2022, an estimated $1.24M.
  • Bellevue Group first reported a position in Repligen in Q4 2019 and held it in 3 quarters.
  • Bellevue Group's Repligen position peaked at $1.31M in Q1 2020.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on Bellevue Group's 13F filing for Q4 2022, filed 14 Feb 2023.